Position in ARGX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$6,494
+$3,573 QoQ
Shares Held
7
+75.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Plante Moran Financial Advisors, LLC holds $543,889 across 38 Biotechnology names. ARGX ranks #6 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RLAY |
Relay Therapeutics, Inc.
|
10,836 | $202,741 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
636 | $191,455 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
171 | $84,940 | |
| 4 | SABS |
SAB Biotherapeutics, Inc.
|
5,925 | $23,107 | |
| 5 | OMER |
Omeros Corp
|
1,000 | $9,510 | |
| 6 | ARGX |
Argenx SE
This page
|
7 | $6,494 | |
| 7 | BHVN |
Biohaven Ltd.
|
362 | $5,386 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
6 | $2,230 |
All Filings in ARGX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,494 | 7 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,921 | 4 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $3,363 | 4 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,950 | 4 | Shares | Sole | 2025-11-05 | |
| No filing history on record for this holder in this stock. | ||||||